{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:01:28Z","timestamp":1790841688777,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010623","name":"University of Thessaly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejim.2026.107136","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:37:41Z","timestamp":1787139461000},"page":"107136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Carbapenem-resistant Acinetobacter baumannii pneumonia: Treatment challenges"],"prefix":"10.1016","volume":"152","author":[{"given":"Demosthenes","family":"Makris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.107136_bib0001","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"7","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ejim.2026.107136_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejim.2026.107136_bib0003","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3390\/antibiotics12081317","article-title":"Comparison between Colistin and Polymyxin B in the treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus Complex","volume":"12","author":"Garcia","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejim.2026.107136_bib0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12941-018-0262-0","article-title":"Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study","volume":"17","author":"Aggarwal","year":"2018","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"7","key":"10.1016\/j.ejim.2026.107136_bib0005","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00134-023-07036-5","article-title":"Aerosolised antibiotics in critical care","volume":"49","author":"Rello","year":"2023","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ejim.2026.107136_bib0006","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/antibiotics12050801","article-title":"Aerosolized antibiotics to manage ventilator-associated infections: a comprehensive review","volume":"12","author":"Myrianthefs","year":"2023","journal-title":"Antibiotics"},{"issue":"5","key":"10.1016\/j.ejim.2026.107136_bib0007","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/cid\/cir934","article-title":"What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression","volume":"54","author":"Florescu","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ejim.2026.107136_bib0008","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jmii.2019.08.007","article-title":"Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex","volume":"53","author":"Zheng","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.ejim.2026.107136_bib0009","doi-asserted-by":"crossref","first-page":"555","DOI":"10.21037\/jtd.2017.02.61","article-title":"Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii","volume":"9","author":"Kim","year":"2017","journal-title":"J Thorac Dis"},{"issue":"9","key":"10.1016\/j.ejim.2026.107136_bib0010","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1473-3099(23)00184-6","volume":"23","author":"Kaye","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ejim.2026.107136_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae140","article-title":"Clinical outcomes for patients with monomicrobial vs polymicrobial Acinetobacter baumannii-calcoaceticus complex infections treated with Sulbactam-Durlobactam or Colistin: a subset analysis from a phase 3 Clinical trial","volume":"11","author":"McLeod","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.ejim.2026.107136_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106596","article-title":"Sulbactam-durlobactam treatment for pulmonary infections caused by carbapenem-resistant Acinetobacter baumannii in lung transplant recipients","volume":"91","author":"Zhang","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.ejim.2026.107136_bib0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","volume":"24","author":"Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ejim.2026.107136_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IDR.S584186","article-title":"Comparison of two different doses of ampicillin-sulbactam as part of combination therapy in the treatment of multidrug resistant Acinetobacter baumannii ventilator associated pneumonia: a randomized clinical trial","volume":"Volume 19","author":"Niknami","year":"2026","journal-title":"Infect Drug Resist"},{"issue":"12","key":"10.1016\/j.ejim.2026.107136_bib0015","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1093\/jac\/dkz337","article-title":"Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis","volume":"74","author":"Mei","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6","key":"10.1016\/j.ejim.2026.107136_bib0016","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.1093\/cid\/ciu593","article-title":"Bad bugs need old drugs: a stewardship program's evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections","volume":"59","author":"Goff","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ejim.2026.107136_bib0017","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s00134-003-1811-2","article-title":"Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"29","author":"Wood","year":"2003","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ejim.2026.107136_bib0018","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant gram-negative bacteria: an open-label, randomised controlled trial","volume":"18","author":"Paul","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ejim.2026.107136_bib0019","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200131","article-title":"Colistin monotherapy versus combination therapy for carbapenem-resistant organisms","volume":"2","author":"Kaye","year":"2023","journal-title":"NEJM Evid"},{"issue":"3","key":"10.1016\/j.ejim.2026.107136_bib0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ejim.2026.107136_bib0021","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1017\/S095026881200194X","article-title":"Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"141","author":"Aydemir","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"10","key":"10.1016\/j.ejim.2026.107136_bib0022","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/jac\/dkaf306","article-title":"Synergistic cefiderocol-containing antibiotic combinations active against highly drug-resistant Acinetobacter baumannii patient isolates with diverse resistance mechanisms","volume":"80","author":"Halim","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.ejim.2026.107136_bib0023","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/antibiotics12061048","article-title":"Effectiveness of first-line therapy with old and novel antibiotics in ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii: a real life, prospective, observational, single-center study","volume":"12","author":"Dalfino","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejim.2026.107136_bib0024","unstructured":"Zhan Y, Mao W, Zhao C, Lu D, Chen C, Hu W, Yang Q. Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial."}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526004413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526004413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:43:14Z","timestamp":1790840594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526004413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0953620526004413"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107136","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbapenem-resistant Acinetobacter baumannii pneumonia: Treatment challenges","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107136"}}